Literature DB >> 10822445

Basilar artery vasospasm in postpartum cerebral angiopathy.

K Y Lee1, Y H Sohn, S H Kim, I N Sunwoo.   

Abstract

The reason cerebral edema in postpartum cerebral angiopathy (PPCA) occurs preferentially in the posterior brain is poorly understood. The authors present two patients with PPCA who showed vasospasm occurring earlier and more severely in the basilar artery than in the middle cerebral artery. Our patients demonstrate the difference in vascular change between the anterior and posterior cerebral vessels, explaining the susceptibility of the posterior brain to PPCA.

Entities:  

Mesh:

Year:  2000        PMID: 10822445     DOI: 10.1212/wnl.54.10.2003

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Atypical reversible eclamptic encephalopathy: utility of diffusion weighted MRI and ADC values.

Authors:  Man Seok Park; Tae Seung Nam; Seung Han Lee; Byeong Chae Kim; Myeong Kyu Kim; Ki Hyun Cho
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

2.  Reversible cerebral angiopathy: efficacy of nimodipine.

Authors:  Mathieu Zuber; Emmanuel Touzé; Valérie Domigo; Denis Trystram; Catherine Lamy; Jean-Louis Mas
Journal:  J Neurol       Date:  2006-10-24       Impact factor: 4.849

3.  Call-Fleming syndrome associated with subarachnoid haemorrhage: three new cases.

Authors:  R R Moustafa; C M C Allen; J-C Baron
Journal:  BMJ Case Rep       Date:  2009-02-02

4.  Cerebrovascular Disease in Pregnancy.

Authors:  Salina Waddy; Barney J. Stern
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-07

5.  Overlapping features of eclampsia and postpartum angiopathy.

Authors:  Jeffrey J Fletcher; Andreas H Kramer; Thomas P Bleck; Nina J Solenski
Journal:  Neurocrit Care       Date:  2009-04-29       Impact factor: 3.210

6.  Cerebrovascular Disease in Pregnancy.

Authors:  Michael A. Sloan; Barney J. Stern
Journal:  Curr Treat Options Neurol       Date:  2003-09       Impact factor: 3.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.